Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Belite Bio Inc (ADR) - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
BLTE
Nasdaq
8731
https://belitebio.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Belite Bio Inc (ADR)
Belite Bio Announces PMDA Submission of Tinlarebant for Stargardt Disease Clinical Trial in Japan
- Mar 22nd, 2024 12:00 pm
Here's Why We're Not Too Worried About Belite Bio's (NASDAQ:BLTE) Cash Burn Situation
- Mar 20th, 2024 11:32 am
Belite Bio Announces Availability of Annual Report on Form 20-F Through Company Website
- Mar 12th, 2024 2:28 am
Belite Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
- Mar 12th, 2024 1:27 am
Belite Bio to Host Webcast on March 12, 2024, to Discuss Fourth Quarter and Full Year 2024 Financial Results
- Mar 6th, 2024 1:00 pm
Belite Bio to Participate in the Leerink Partners Global Biopharma Conference
- Mar 4th, 2024 1:00 pm
Belite Bio to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
- Feb 7th, 2024 1:00 pm
Is There An Opportunity With Belite Bio, Inc's (NASDAQ:BLTE) 49% Undervaluation?
- Jan 9th, 2024 10:36 am
Belite Bio to Participate in the Benchmark Company’s Upcoming Discovery One-on-One Investor Conference
- Nov 30th, 2023 1:00 pm
Belite Bio to Participate in the BTIG Ophthalmology Day
- Nov 20th, 2023 1:00 pm
Belite Bio Reports Third Quarter 2023 Operational Highlights and Financial Results
- Nov 14th, 2023 1:15 am
Deutsche Bank ADR Investor Conference: Presentations Now Available for Online Viewing
- Nov 10th, 2023 1:35 pm
Belite Bio to Host Webcast on November 14, 2023, to Discuss Third Quarter 2023 Financial Results
- Nov 7th, 2023 1:00 pm
Belite Bio, Inc. to present at the Deutsche Bank ADR Virtual Investor Conference on 8 November 2023
- Nov 6th, 2023 9:00 pm
Belite Bio Presents Results from a 24-month, Phase 2 Study of Tinlarebant in Childhood-onset Stargardt Disease at the AAO Annual Meeting
- Nov 6th, 2023 1:00 pm
International companies to host live webcasts at Deutsche Bank’s Depositary Receipts
- Nov 1st, 2023 12:35 pm
International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on November 8th and 9th, 2023
- Nov 1st, 2023 12:35 am
Belite Bio Announces Presentation at the American Academy of Ophthalmology 2023 Annual Meeting
- Oct 27th, 2023 12:00 pm
Belite Bio (BLTE) Stock Surges 72% in a Month: Here's Why
- Aug 21st, 2023 3:12 pm
Belite Bio Reports Second Quarter 2023 Operational Highlights and Financial Results
- Aug 9th, 2023 2:17 am
Scroll